ViewRay has announced it has received FDA 510(k) clearance for its MRI-guided radiation therapy system, according to a news release. Features of the ViewRay system, which is designed for the treatment ...
Total revenue of $102.2 million primarily from 16 revenue units including one upgrade, compared to 2021 revenue of approximately $70.1 million, primarily from ten revenue units. Received a total of 32 ...
DENVER, Nov. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (MRXC) (NASDAQ: VRAY) announced today that the Company will present at the Stifel 2022 Healthcare Conference. Scott Drake, President and Chief ...
ViewRay, Inc. designs, manufactures, and markets the MRIdian MRI-guided Radiation Therapy System. It develops MRIdian to address the limitations of existing external-beam radiation therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results